Eli Lilly (NYSE:LLY) is making a $5.3 billion investment to expand manufacturing for its high-demand anti-obesity drug Zepbound ...

On Monday, Barclays expressed a positive stance on Eli Lilly (NYSE:LLY) stock, maintaining an Overweight rating and a price target ...

AbbVie Inc. enters the obesity market with GUBamy, a promising amylin analog. Click here to find out why ABBV stock is a Buy.

Novo Nordisk faces formidable challenges from Eli Lilly and new rivals, but its first-mover advantage and expanded ...

Giftify (GIFT) announced a significant increase in gift card sales following its announcement of a smart savings program for GLP-1 diabetes and ...

The Stock Exchange of Thailand has registered six new Depositary Receipts (DR) and Depositary Receipts Express (DRx), referencing shares of Chinese and US companies, which started trading on 11th May ...

(LILAMAX) – Starbucks will add seating and power outlets to attract customers, and nearly 9-million Americans have multiple ...

Results of positron emission tomography (PET) trial and second multiple ascending dose (MAD-2) trial support RAP-219's transformative potential ...

Uncertainty around President Donald Trump’s tariff policies have sent the major averages on a roller-coaster ride and spurred ...

New York, New York--(Newsfile Corp. - January 17, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds... Investing.com – United States equities were higher at the close on Friday, ...